Caliper Life Sciences Inc.

Caliper Life Sciences Inc. of Hopkinton, Mass., has signed a multiyear license agreement with Novartis International AG of Basel, Switzerland, in which the latter company will have access to its partner’s noninvasive in vivo optical imaging methods. Among the technologies covered under the agreement are instruments from Caliper’s Xenogen product line, including a system that allows both bioluminescence and fluorescence imaging.





LATEST NEWS

• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024
• One-Step Hologram Generation Speeds 3D Display Creation
  Apr 24, 2024
• Innovation Award Winners for Laser Technology Honored in Aachen
  Apr 23, 2024
• Intech 2024: AI Arrives on the Shop Floor
  Apr 22, 2024